fulvestrant has been researched along with calcitriol in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Binderup, L; Colston, KW; James, SY; Mackay, AG | 1 |
Barto, R; Netelenbos, JC; Ten Bolscher, M; Van Buuren, LM; Van der vijgh, WJ | 1 |
Bogart, DF; Li, P; Lupu, R; Mehmi, I; Tsai, MS | 1 |
Chaumaz, G; Cournot, G; Lieberherr, M; Pointillart, A; Rassi, CM | 1 |
Christensen, GL; Christensen, IJ; Fog, CK; Jepsen, JS; Lykkesfeldt, AE | 1 |
Astudillo, P; Fernández, M; Leiva, L; Pino, AM; Ríos, S; Rodríguez, JM; Rodríguez, JP; Seitz, G | 1 |
Avila, E; Barrera, D; Camacho, J; Díaz, L; Esparza-López, J; García-Becerra, R; García-Quiroz, J; Halhali, A; Ibarra-Sánchez, MJ; Larrea, F; Medina-Franco, H; Ordaz-Rosado, D; Santos-Martínez, N | 1 |
1 review(s) available for fulvestrant and calcitriol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for fulvestrant and calcitriol
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Time Factors; Tumor Cells, Cultured | 1994 |
Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat.
Topics: Animals; Calcitriol; Calcium; Duodenum; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Intestinal Absorption; Ovariectomy; Rats; Rats, Wistar; Receptors, Estrogen | 1999 |
Expression and regulation of Cyr61 in human breast cancer cell lines.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Breast Neoplasms; Calcitriol; Cysteine-Rich Protein 61; Drug Resistance; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Immediate-Early; Growth Substances; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phenotype; Protein Structure, Tertiary; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Selective Estrogen Receptor Modulators; Tamoxifen; Tetradecanoylphorbol Acetate; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured | 2002 |
Down-regulation of osteoclast differentiation by daidzein via caspase 3.
Topics: Acid Phosphatase; Animals; Apoptosis; Bone Marrow Cells; Calcitriol; Caspase 3; Caspases; Cell Differentiation; Cells, Cultured; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Fulvestrant; Isoenzymes; Isoflavones; Osteoclasts; Receptors, Estrogen; Swine; Tartrate-Resistant Acid Phosphatase | 2002 |
Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.
Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; Genes, bcl-2; Humans; Predictive Value of Tests; Receptors, Calcitriol; Receptors, Estrogen; Tamoxifen; Vitamin D | 2004 |
Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin.
Topics: Adipocytes; Aged; Aged, 80 and over; Analysis of Variance; Aromatase; Aromatase Inhibitors; Blotting, Western; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Leptin; Mesenchymal Stem Cells; Microscopy, Fluorescence; Osteoblasts; Vitamin D | 2006 |
Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
Topics: Breast Neoplasms; Calcitriol; Cell Line, Tumor; Cyclin D1; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Receptors, Calcitriol | 2014 |